Poor outcome for neonatal-type nonketotic hyperglycinemia treated with high-dose sodium benzoate and dextromethorphan

Journal of Child Neurology

Volumn 19, Issue 1, 2004, Pages 39-42

  Chien, Yin Hsiu ^a   Hsu, Chia Chi ^a   Huang, Aichu ^a   Chou, Shi Ping ^a   Lu, Frank Li ^a   Lee, Wang Tso ^a   Hwu, Wuh Liang ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BENZOIC ACID; DEXTROMETHORPHAN; GLYCINE; KETAMINE;

AMINO ACID BLOOD LEVEL; ANAMNESIS; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CLINICAL PROTOCOL; DECISION MAKING; DISEASE CLASSIFICATION; DISEASE SEVERITY; DOSE RESPONSE; DRUG MEGADOSE; FAMILY COUNSELING; GASTROINTESTINAL SYMPTOM; GENETIC COUNSELING; HUMAN; HYPERGLYCINEMIA; INFANT; INTRACTABLE EPILEPSY; MENTAL DEFICIENCY; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; RESUSCITATION; SEDATION; SIDE EFFECT; STANDARDIZATION; TREATMENT OUTCOME;

EID: 1542603300     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/08830738040190010702     Document Type: Article

References (13)

1. Hamosh A, Johnston MV: Nonketotic hyperglycinemia, in Scriver CR, Beaudet AL, Sly WS, Valle D (eds): The Metabolic and Molecular Bases of Inherited Disease, 8th ed. New York, McGraw-Hill, 2065-2078.
2. Tada K, Hayasaka K: Non-ketotic hyperglycinaemia: Clinical and bio-chemical aspects. Eur J Pediatr 1987;146:221-227.
3. Applegarth DA, Toone JR: Nonketotic hyperglycinemia (glycine encephalopathy): Laboratory diagnosis. Mol Genet Metab 2001; 74:139-146.
4. Hamosh A, Maher JF, Bellus GA, et al: Long-term use of high-dose benzoate and dextromethorphan for the treatment of nonketotic hyperglycinemia. J Pediatr 1998;132:709-713.
5. Lu FL, Wang PJ, Hwu WL, et al: Neonatal type of nonketotic hyperglycinemia. Pediatr Neurol 1999;20:295-300.
6. Chen PT, Young C, Lee WT, et al: Early epileptic encephalopathy with suppression burst electroencephalographic pattern - An analysis of eight Taiwanese patients. Brain Dev 2001;23:715-720.
7. Hamosh A, McDonald JW, Valle D, et al: Dextromethorphan and high-dose benzoate therapy for nonketotic hyperglycinemia in an infant. J Pediatr 1992;121:131-135.
8. Zammarchi E, Donati MA, Ciani F, et al: Failure of early dextromethorphan and sodium benzoate therapy in an infant with nonketotic hyperglycinemia. Neuropediatrics 1994;25:274-276.
9. Hayasaka K, Tada K, Fueki N, Aikawa J: Prenatal diagnosis of nonketotic hyperglycinemia: Enzymatic analysis of the glycine cleavage system in chorionic villi. J Pediatr 1990;116:444-445.
10. Kure S, Rolland MO, Leisti J, et al: Prenatal diagnosis of nonketotic hyperglycinemia: Enzymatic diagnosis in 28 families and DNA diagnosis detecting prevalent Finnish and Israeli-Arab mutations. Prenat Diagn, 1999;19:717-720.
11. Applegarth DA, Toone JR, Rolland MO, et al: Non-concordance of CVS and liver glycine cleavage enzyme in three families with non-ketotic hyperglycinaemia (NKH) leading to false negative prenatal diagnoses. Prenat Diagn 2000;20:367 370.
12. Toone JR, Applegarth DA, Coulter-Mackie MB, James ER: Recurrent mutations in P- and T-proteins of the glycine cleavage complex and a novel T-protein mutation (N1451): A strategy for the molecular investigation of patients with nonketotic hyperglycinemia (NKH). Mol Genet Metab 2001;72:322-325.
13. Takayanagi M, Kure S, Sakata Y, et al: Human glycine decarboxylase gene (GLDC) and its highly conserved processed pseudogene (psiGLDC): Their structure and expression, and the identification of a large deletion in a family with nonketotic hyperglycinemia. Hum Genet 2000;106:298-305.